{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:23:12Z","timestamp":1790374992699,"version":"4.1.0"},"reference-count":195,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170027"],"award-info":[{"award-number":["82170027"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.phymed.2022.154259","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T23:25:30Z","timestamp":1656545130000},"page":"154259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Artesunate: A review of its therapeutic insights in respiratory diseases"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5046-6106","authenticated-orcid":false,"given":"Jingyuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6019-2011","authenticated-orcid":false,"given":"Mengyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0228-572X","authenticated-orcid":false,"given":"Jiangtao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2022.154259_bib0001","article-title":"Novel aspects of pathogenesis and regeneration mechanisms in COPD","volume":"995","author":"Aldonyte","year":"2015","journal-title":"COPD"},{"key":"10.1016\/j.phymed.2022.154259_bib0002","doi-asserted-by":"crossref","first-page":"e89866","DOI":"10.1371\/journal.pone.0089866","article-title":"Finding the best thresholds of FEV1 and dyspnea to predict 5-year survival in COPD patients: the COCOMICS study","volume":"9","author":"Almagro","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2022.154259_bib0003","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(08)61452-X","article-title":"Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease","volume":"372","author":"Anderson","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2022.154259_bib0004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/13596535211064078","article-title":"Impact of new cyclooxygenase 2 inhibitors on human cytomegalovirus replication in vitro","volume":"26","author":"Andouard","year":"2021","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.phymed.2022.154259_bib0005","doi-asserted-by":"crossref","first-page":"e10370","DOI":"10.1371\/journal.pone.0010370","article-title":"Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers","volume":"5","author":"Arav-Boger","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2022.154259_bib0006","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jviromet.2011.03.005","article-title":"A reporter system for Epstein-Barr virus (EBV) lytic replication: anti-EBV activity of the broad anti-herpesviral drug artesunate","volume":"173","author":"Auerochs","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.phymed.2022.154259_bib0007","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/004947550403400302","article-title":"Pharmacokinetics of artesunate following oral and rectal administration in healthy Sudanese volunteers","volume":"34","author":"Awad","year":"2004","journal-title":"Trop. Doct."},{"key":"10.1016\/j.phymed.2022.154259_bib0008","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4269\/ajtmh.2002.66.130","article-title":"Relative bioavailability of artesunate and dihydroartemisinin: investigations in the isolated perfused rat liver and in healthy Caucasian volunteers","volume":"66","author":"Batty","year":"2002","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.phymed.2022.154259_bib0009","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2125.1998.00655.x","article-title":"A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria","volume":"45","author":"Batty","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0010","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4269\/ajtmh.1998.59.823","article-title":"A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria","volume":"59","author":"Batty","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.phymed.2022.154259_bib0011","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4269\/ajtmh.1997.56.17","article-title":"Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers","volume":"56","author":"Benakis","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.phymed.2022.154259_bib0012","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2125.2001.01395.x","article-title":"Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria","volume":"51","author":"Binh","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0013","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1182\/blood-2008-10-143560","article-title":"How we treat cytomegalovirus in hematopoietic cell transplant recipients","volume":"113","author":"Boeckh","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2022.154259_bib0014","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/all.13840","article-title":"Changes in the prevalence of asthma and respiratory symptoms in western Sweden between 2008 and 2016","volume":"74","author":"Borna","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.phymed.2022.154259_bib0015","doi-asserted-by":"crossref","first-page":"17723","DOI":"10.1073\/pnas.0509235102","article-title":"Allergen-induced peribronchial fibrosis and mucus production mediated by IkappaB kinase beta-dependent genes in airway epithelium","volume":"102","author":"Broide","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phymed.2022.154259_bib0016","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5858\/arpa.2015-0519-RA","article-title":"Acute lung injury: a clinical and molecular review","volume":"140","author":"Butt","year":"2016","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.phymed.2022.154259_bib0017","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1475-2875-11-132","article-title":"Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults","volume":"11","author":"Byakika-Kibwika","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.phymed.2022.154259_bib0018","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.jaci.2021.03.035","article-title":"Airway smooth muscle pathophysiology in asthma","volume":"147","author":"Camoretti-Mercado","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.phymed.2022.154259_bib0019","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10753-015-0290-2","article-title":"Artesunate protects against sepsis-induced lung injury via heme oxygenase-1 modulation","volume":"39","author":"Cao","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.phymed.2022.154259_bib0020","doi-asserted-by":"crossref","first-page":"E5071","DOI":"10.3390\/ijerph17145071","article-title":"Asthma mortality and hospitalizations in Mexico from 2010 to 2018: retrospective Epidemiologic profile","volume":"17","author":"Carrillo","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.phymed.2022.154259_bib0021","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2022.154259_bib0022","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1386-6532(01)00149-4","article-title":"Epstein-Barr virus (EBV) infection in infancy","volume":"21","author":"Chan","year":"2001","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.phymed.2022.154259_bib0023","first-page":"34","article-title":"Investigation of bioavailability, pharmacokinetics and safety of new pediatric formulations of artesunate and mefloquine","volume":"36","author":"Chanthap","year":"2005","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.phymed.2022.154259_bib0024","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2022.154259_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110167","article-title":"Artesunate induces apoptosis, autophagy and ferroptosis in diffuse large B cell lymphoma cells by impairing STAT3 signaling","volume":"88","author":"Chen","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phymed.2022.154259_bib0027","doi-asserted-by":"crossref","first-page":"e20932","DOI":"10.1371\/journal.pone.0020932","article-title":"Anti-malarial drug artesunate attenuates experimental allergic Asthma via inhibition of the phosphoinositide 3-Kinase\/Akt Pathway","volume":"6","author":"Cheng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2022.154259_bib0028","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/all.12077","article-title":"Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models","volume":"68","author":"Cheng","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.phymed.2022.154259_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104901","article-title":"Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases","volume":"158","author":"Cheong","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2022.154259_bib0030","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1128\/AAC.00365-11","article-title":"Pharmacokinetics and ex vivo antimalarial activity of artesunate-azithromycin in healthy volunteers","volume":"55","author":"Chinh","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0031","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.antiviral.2011.07.018","article-title":"The unique antiviral activity of artesunate is broadly effective against human cytomegaloviruses including therapy-resistant mutants","volume":"92","author":"Chou","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.phymed.2022.154259_bib0032","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/ph14100954","article-title":"A drug repurposing approach for antimalarials interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and human angiotensin-converting Enzyme 2 (ACE2)","volume":"14","author":"Coghi","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.phymed.2022.154259_bib0033","first-page":"39","article-title":"Traditional Chinese medicine and related active compounds against hepatitis B virus infection","volume":"4","author":"Cui","year":"2010","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.phymed.2022.154259_bib0034","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1128\/AAC.45.1.181-186.2001","article-title":"Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria","volume":"45","author":"Davis","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0035","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/AAC.01253-06","article-title":"Assessment of the effect of mefloquine on artesunate pharmacokinetics in healthy male volunteers","volume":"51","author":"Davis","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0036","article-title":"Asthma mortality in Spain from 1980 to 2019. Trends and perspectives in new treatment era","volume":"0","author":"Delgado-Romero","year":"2021","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.phymed.2022.154259_bib0037","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12890-016-0208-2","article-title":"Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory?","volume":"16","author":"Demarche","year":"2016","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.phymed.2022.154259_bib0038","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2022.154259_bib0039","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3851\/IMP3028","article-title":"Artesunate demonstrates in vitro synergism with several antiviral agents against human cytomegalovirus","volume":"21","author":"Drouot","year":"2016","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.phymed.2022.154259_bib0040","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00280-009-1095-5","article-title":"Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo","volume":"65","author":"Du","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0041","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein-Barr virus infection","volume":"102","author":"Dunmire","year":"2018","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.phymed.2022.154259_bib0042","first-page":"767","article-title":"The anti-malarial artesunate is also active against cancer","volume":"18","author":"Efferth","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.phymed.2022.154259_bib0043","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00109-001-0300-8","article-title":"Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses","volume":"80","author":"Efferth","year":"2002","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.phymed.2022.154259_bib0044","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/mol.64.2.382","article-title":"Molecular modes of action of artesunate in tumor cell lines","volume":"64","author":"Efferth","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0045","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2147\/IDR.S180908","article-title":"Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review","volume":"12","author":"El Helou","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.phymed.2022.154259_bib0046","doi-asserted-by":"crossref","first-page":"517","DOI":"10.18632\/oncoscience.160","article-title":"Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells","volume":"2","author":"Eling","year":"2015","journal-title":"Oncoscience"},{"key":"10.1016\/j.phymed.2022.154259_bib0047","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/cea.12481","article-title":"Resistin-like molecule-\u03b2 (RELM-\u03b2) targets airways fibroblasts to effect remodelling in asthma: from mouse to man","volume":"45","author":"Fang","year":"2015","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.phymed.2022.154259_bib0048","article-title":"Nevirapine-based antiretroviral therapy impacts artesunate and dihydroartemisinin disposition in HIV-infected nigerian adults","volume":"2012","author":"Fehintola","year":"2012","journal-title":"AIDS Res. Treat."},{"key":"10.1016\/j.phymed.2022.154259_bib0049","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/jac\/dkt346","article-title":"Stability and antiviral activity against human cytomegalovirus of artemisinin derivatives","volume":"69","author":"Flobinus","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00228-010-0911-5","article-title":"Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers","volume":"67","author":"Fortin","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0051","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/1475-2875-9-291","article-title":"Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety","volume":"9","author":"Frey","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.phymed.2022.154259_bib0052","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.biochi.2014.10.001","article-title":"Inhibition of autophagy by chloroquine potentiates synergistically anti-cancer property of artemisinin by promoting ROS dependent apoptosis","volume":"107","author":"Ganguli","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.phymed.2022.154259_bib0053","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2022.154259_bib0054","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.it.2013.04.002","article-title":"Living and dying for inflammation: neutrophils, eosinophils, basophils","volume":"34","author":"Geering","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.phymed.2022.154259_bib0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2213-2600(18)30502-2","article-title":"Lung transplantation for idiopathic pulmonary fibrosis","volume":"7","author":"George","year":"2019","journal-title":"Lancet Respir. Med"},{"key":"10.1016\/j.phymed.2022.154259_bib0056","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2013.10.014","article-title":"Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus","volume":"101","author":"Germi","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.phymed.2022.154259_bib0057","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4269\/ajtmh.1998.58.365","article-title":"Plasma levels of artesunate and dihydroartemisinin in children with Plasmodium falciparum malaria in Gabon after administration of 50-milligram artesunate suppositories","volume":"58","author":"Halpaap","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.phymed.2022.154259_bib0058","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2015.07.007","article-title":"Barrier epithelial cells and the control of Type 2 immunity","volume":"43","author":"Hammad","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.phymed.2022.154259_bib0059","first-page":"3902","article-title":"Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia","volume":"8","author":"Hans-Uwe","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.phymed.2022.154259_bib0060","first-page":"4032","article-title":"Airway Uric acid is a sensor of inhaled protease allergens and initiates type 2 immune responses in respiratory mucosa","volume":"192","author":"Hara","year":"2014","journal-title":"J.I"},{"key":"10.1016\/j.phymed.2022.154259_bib0061","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1128\/AAC.48.11.4234-4239.2004","article-title":"Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria","volume":"48","author":"Hien","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0062","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.freeradbiomed.2012.05.021","article-title":"Anti-malarial drug artesunate ameliorates oxidative lung damage in experimental allergic asthma","volume":"53","author":"Ho","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phymed.2022.154259_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-Barr virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2022.154259_bib0064","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.phymed.2022.154259_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.680127","article-title":"Artemether, Artesunate, Arteannuin B, Echinatin, Licochalcone B and Andrographolide Effectively Inhibit SARS-CoV-2 and Related Viruses In Vitro","volume":"11","author":"Hu","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.phymed.2022.154259_bib0066","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2022.154259_bib0067","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.00185114","article-title":"Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review","volume":"46","author":"Hutchinson","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phymed.2022.154259_bib0068","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nm1617","article-title":"Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells","volume":"13","author":"Idzko","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2022.154259_bib0069","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.0306-5251.2001.01519.x","article-title":"The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria","volume":"53","author":"Ilett","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1517\/14728214.2015.1000299","article-title":"Emerging drugs for acute lung injury","volume":"20","author":"Impellizzeri","year":"2015","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.phymed.2022.154259_bib0071","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1183\/09031936.00174612","article-title":"Alveolar macrophage proteinase\/antiproteinase expression in lung function and emphysema","volume":"43","author":"Ishii","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phymed.2022.154259_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172953","article-title":"Evaluation of artesunate for the treatment of adult T-cell leukemia\/lymphoma","volume":"872","author":"Ishikawa","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0073","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.7754\/Clin.Lab.2015.141244","article-title":"Artesunate attenuates lung injury in paraquat-intoxicated rats via downregulation of inflammatory Cytokines","volume":"61","author":"Jiang","year":"2015","journal-title":"Clin. Lab."},{"key":"10.1016\/j.phymed.2022.154259_bib0074","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/AAC.03829-14","article-title":"Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects","volume":"59","author":"Jittamala","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2005.10.003","article-title":"The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo","volume":"69","author":"Kaptein","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.phymed.2022.154259_bib0076","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00044011-199815010-00005","article-title":"Pharmacokinetics of oral artesunate in Thai patients with uncomplicated falciparum malaria","volume":"15","author":"Karbwang","year":"1998","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.phymed.2022.154259_bib0077","doi-asserted-by":"crossref","first-page":"e2975","DOI":"10.1371\/journal.pntd.0002975","article-title":"Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial","volume":"8","author":"Keiser","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.phymed.2022.154259_bib0078","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2011.03.015","article-title":"An unexpected role for uric acid as an inducer of T Helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic Asthma","volume":"34","author":"Kool","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.phymed.2022.154259_bib0079","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/AAC.45.2.509-516.2001","article-title":"Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria","volume":"45","author":"Krishna","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0080","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1128\/AAC.01187-09","article-title":"New Fixed-Dose artesunate-mefloquine formulation against multidrug-resistant plasmodium falciparum in Adults: a Comparative Phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus Mefloquine","volume":"54","author":"Krudsood","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0081","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057689","article-title":"Reduced susceptibility of plasmodium falciparum to Artesunate in Southern Myanmar","volume":"8","author":"Kyaw","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2022.154259_bib0082","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ni.3049","article-title":"The immunology of asthma","volume":"16","author":"Lambrecht","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phymed.2022.154259_bib0083","doi-asserted-by":"crossref","first-page":"L414","DOI":"10.1152\/ajplung.00346.2010","article-title":"Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma","volume":"300","author":"Le Cras","year":"2011","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.phymed.2022.154259_bib0084","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2022.154259_bib0085","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0163-7258(90)90053-5","article-title":"Metabolism of antimalarial sesquiterpene lactones","volume":"48","author":"Lee","year":"1990","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2022.154259_bib0086","first-page":"3199","article-title":"Artesunate restraining MAPK passage by smad7 to resist pulmonary fibrosis","volume":"18","author":"Li","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.phymed.2022.154259_bib0087","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4269\/ajtmh.2009.09-0150","article-title":"Pharmacokinetic profiles of artesunate after single intravenous doses at 0.5, 1, 2, 4, and 8mg\/kg in healthy volunteers: a phase I study","volume":"81","author":"Li","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.phymed.2022.154259_bib0089","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3390\/ph3072322","article-title":"Artesunate: the best drug in the treatment of severe and complicated malaria","volume":"3","author":"Li","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.phymed.2022.154259_bib0090","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","article-title":"Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma","volume":"42","author":"Li","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2022.154259_bib0091","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/ijc.25707","article-title":"The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies","volume":"128","author":"Liu","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phymed.2022.154259_bib0092","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1128\/AAC.02617-14","article-title":"A replicate designed bioequivalence study to compare two fixed-dose combination products of artesunate and amodiaquine in healthy Chinese volunteers","volume":"58","author":"Liu","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0093","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3892\/etm.2017.4573","article-title":"Artesunate ameliorates lung fibrosis via inhibiting the Notch signaling pathway","volume":"14","author":"Liu","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.phymed.2022.154259_bib0094","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s10753-018-0801-z","article-title":"Artesunate inhibits renal ischemia-reperfusion-mediated remote lung inflammation through attenuating ROS-Induced activation of NLRP3 inflammasome","volume":"41","author":"Liu","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.phymed.2022.154259_bib0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10753-017-0669-3","article-title":"Artesunate inhibits renal ischemia reperfusion-stimulated lung inflammation in rats by activating HO-1 pathway","volume":"41","author":"Liu","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.phymed.2022.154259_bib0096","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.intimp.2015.11.016","article-title":"The anti-malaria drug artesunate inhibits cigarette smoke and ovalbumin concurrent exposure-induced airway inflammation and might reverse glucocorticoid insensitivity","volume":"29","author":"Luo","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0097","doi-asserted-by":"crossref","first-page":"10556","DOI":"10.3390\/molecules161210556","article-title":"The effects of artesunate on the expression of EGFR and ABCG2 in A549 human lung cancer cells and a xenograft model","volume":"16","author":"Ma","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2022.154259_bib0098","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1016\/j.transproceed.2018.02.091","article-title":"Resistant cytomegalovirus infection in solid-organ transplantation: single-center experience, literature review of risk factors, and proposed preventive strategies","volume":"50","author":"Majeed","year":"2018","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.phymed.2022.154259_bib0099","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1067\/mai.2002.125977","article-title":"The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis","volume":"110","author":"Makabe-Kobayashi","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.phymed.2022.154259_bib0100","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3201\/eid2609.202095","article-title":"Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States","volume":"26","author":"Martines","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.phymed.2022.154259_bib0101","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/mi.2012.105","article-title":"The ER stress transducer IRE1\u03b2 is required for airway epithelial mucin production","volume":"6","author":"Martino","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.phymed.2022.154259_bib0102","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4269\/ajtmh.13-0283","article-title":"Pharmacokinetics of artesunate alone and in combination with sulfadoxine\/pyrimethamine in healthy Sudanese volunteers","volume":"90","author":"Matar","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.phymed.2022.154259_bib0103","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2125.2011.04103.x","article-title":"Artesunate\/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects","volume":"73","author":"McGready","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0104","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaci.2009.08.035","article-title":"Mechanisms of mast cell signaling in anaphylaxis","volume":"124","author":"Metcalfe","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.phymed.2022.154259_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120426","article-title":"Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells","volume":"10","author":"Mi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2022.154259_bib0106","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00228-009-0672-1","article-title":"Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria","volume":"65","author":"Miller","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0107","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1475-2875-11-255","article-title":"Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8mg\/kg in healthy volunteers: phase 1b study","volume":"11","author":"Miller","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.phymed.2022.154259_bib0108","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.placenta.2014.11.003","article-title":"Ex vivo model of congenital cytomegalovirus infection and new combination therapies","volume":"36","author":"Mor\u00e8re","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.phymed.2022.154259_bib0109","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4269\/ajtmh.2012.11-0558","article-title":"Drug-drug interaction analysis of Pyronaridine\/Artesunate and ritonavir in healthy volunteers","volume":"86","author":"Morris","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.phymed.2022.154259_bib0110","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.canlet.2016.09.002","article-title":"COPD, emphysema and the onset of lung cancer. A systematic review","volume":"382","author":"Mouronte-Roib\u00e1s","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2022.154259_bib0111","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1080\/07391102.2020.1796809","article-title":"Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19","volume":"39","author":"Moussa","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.phymed.2022.154259_bib0112","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/AAC.00679-09","article-title":"Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala","volume":"54","author":"Mwesigwa","year":"2010","journal-title":"Uganda. Antimicrobial Agent. Chemotherapy"},{"key":"10.1016\/j.phymed.2022.154259_bib0113","first-page":"575","article-title":"The pharmacokinetics of oral dihydroartemisinin and artesunate in healthy Thai volunteers","volume":"35","author":"Na-Bangchang","year":"2004","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.phymed.2022.154259_bib0114","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1183\/09059180.00002512","article-title":"Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature","volume":"21","author":"Nalysnyk","year":"2012","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.phymed.2022.154259_bib0115","first-page":"81","article-title":"Diagnosis and treatment protocol for COVID-19 patients (Tentative 8th Edition)","volume":"14","year":"2021","journal-title":"Chin. J. Clin. Infect. Dis."},{"key":"10.1016\/j.phymed.2022.154259_bib0116","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s002280050484","article-title":"Comparative pharmacokinetic study of oral and rectal formulations of artesunic acid in healthy volunteers","volume":"54","author":"Navaratnam","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0117","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00228-009-0656-1","article-title":"Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers","volume":"65","author":"Navaratnam","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0118","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1128\/AAC.46.12.3933-3939.2002","article-title":"Intramuscular bioavailability and clinical efficacy of artesunate in Gabonese children with severe malaria","volume":"46","author":"Nealon","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0119","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.44.4.972-977.2000","article-title":"Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria","volume":"44","author":"Newton","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0120","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00228-006-0203-2","article-title":"The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria","volume":"62","author":"Newton","year":"2006","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0121","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.phymed.2014.07.018","article-title":"Anti-malarial drug artesunate protects against cigarette smoke-induced lung injury in mice","volume":"21","author":"Ng","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2022.154259_bib0122","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1083\/jcb.200501111","article-title":"Fc\u03b5RI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane","volume":"170","author":"Nishida","year":"2005","journal-title":"J. Cell Biol."},{"issue":"1985","key":"10.1016\/j.phymed.2022.154259_bib0123","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1152\/japplphysiol.01489.2012","article-title":"Airway narrowing and bronchodilation to deep inspiration in bronchial segments from subjects with and without reported asthma","volume":"114","author":"Noble","year":"2013","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.phymed.2022.154259_bib0124","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.4049\/jimmunol.179.7.4766","article-title":"Analysis of eosinophil turnover in vivo reveals their active recruitment to and prolonged survival in the peritoneal cavity","volume":"179","author":"Ohnmacht","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.phymed.2022.154259_bib0125","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00288-18","article-title":"The artemisinin derivative artemisone is a potent inhibitor of human cytomegalovirus replication","volume":"62","author":"Oiknine-Djian","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0126","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-10-49","article-title":"Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic plasmodium falciparum infections in Kinshasa DRC","volume":"10","author":"Onyamboko","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.phymed.2022.154259_bib0127","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.phymed.2015.08.002","article-title":"Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells","volume":"22","author":"Ooko","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2022.154259_bib0128","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00228-007-0452-8","article-title":"Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers","volume":"64","author":"Orrell","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1475-2875-6-25","article-title":"Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia","volume":"6","author":"Osorio","year":"2007","journal-title":"Malar. J."},{"key":"10.1016\/j.phymed.2022.154259_bib0130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2184.2012.00845.x","article-title":"Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis","volume":"45","author":"Ouyang","year":"2012","journal-title":"Cell Prolif."},{"key":"10.1016\/j.phymed.2022.154259_bib0131","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12931-021-01687-y","article-title":"Artesunate ameliorates cigarette smoke-induced airway remodelling via PPAR-\u03b3\/TGF-\u03b21\/Smad2\/3 signalling pathway","volume":"22","author":"Pan","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.phymed.2022.154259_bib0132","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(20)30053-9","article-title":"Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial","volume":"8","author":"Pavord","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.phymed.2022.154259_bib0133","first-page":"S87","article-title":"Fibroblast phenotypes in pulmonary fibrosis","volume":"29","author":"Phan","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.phymed.2022.154259_bib0134","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jped.2019.02.006","article-title":"Asthma mortality in children and adolescents of Brazil over a 20-year period","volume":"96","author":"Pitchon","year":"2020","journal-title":"J. Pediatr. (Rio. J)"},{"key":"10.1016\/j.phymed.2022.154259_bib0135","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1126\/science.1221064","article-title":"New Paradigms in Type 2 Immunity","volume":"337","author":"Pulendran","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.phymed.2022.154259_bib0136","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","article-title":"Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-\u03b2 and promotes tumor invasion and angiogenesis","volume":"14","author":"Qin","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.phymed.2022.154259_bib0137","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1086\/591096","article-title":"Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon","volume":"198","author":"Ramharter","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.phymed.2022.154259_bib0138","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/ijc.25315","article-title":"First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases","volume":"127","author":"Rasheed","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phymed.2022.154259_bib0139","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.phymed.2018.09.167","article-title":"Dried leaf Artemisia annua efficacy against non-small cell lung cancer","volume":"52","author":"Rassias","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2022.154259_bib0140","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-015-0916-8","article-title":"Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults","volume":"14","author":"Rattanapunya","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.phymed.2022.154259_bib0141","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1021\/acs.chemrestox.5b00105","article-title":"Untargeted proteomics and systems-based mechanistic investigation of artesunate in human bronchial epithelial cells","volume":"28","author":"Ravindra","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.phymed.2022.154259_bib0142","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet N. Am. Ed."},{"key":"10.1016\/j.phymed.2022.154259_bib0143","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2005.07.005","article-title":"Effect of artemisinin\/artesunate as inhibitors of hepatitis B virus production in an \u201cin vitro\u201d replicative system","volume":"68","author":"Romero","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.phymed.2022.154259_bib0144","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri3341","article-title":"Eosinophils: changing perspectives in health and disease","volume":"13","author":"Rosenberg","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phymed.2022.154259_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226436","article-title":"Primary Epstein-Barr virus infection with and without infectious mononucleosis","volume":"14","author":"Rostgaard","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2022.154259_bib0146","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1128\/AAC.00262-15","article-title":"Inhibition of human cytomegalovirus replication by Artemisinins: effects mediated through cell cycle modulation","volume":"59","author":"Roy","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0147","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1074\/jbc.RA120.014116","article-title":"Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibition","volume":"295","author":"Roy","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2022.154259_bib0148","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1074\/jbc.RA120.014116","article-title":"Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibition","volume":"295","author":"Roy","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2022.154259_bib0149","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1128\/AAC.00044-12","article-title":"Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated plasmodium falciparum malaria in western Cambodia","volume":"56","author":"Saunders","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0150","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.4049\/jimmunol.165.4.2205","article-title":"Inducible expression of a Th2-Type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells","volume":"165","author":"Sekiya","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.phymed.2022.154259_bib0151","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/587106","article-title":"Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation","volume":"46","author":"Shapira","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.phymed.2022.154259_bib0152","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF03191163","article-title":"Pharmacokinetics and pharmacodynamics of a new ACT formulation: artesunate\/Amodiaquine (TRIMALACT (R)) following oral administration in African malaria patients","volume":"34","author":"Sinou","year":"2009","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.phymed.2022.154259_bib0153","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1473-3099(16)30020-2","article-title":"Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial","volume":"16","author":"Sirima","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.phymed.2022.154259_bib0154","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1179\/146532807X170466","article-title":"Comparative study of the effectiveness and pharmacokinetics of two rectal artesunate oral mefloquine combination regimens for the treatment of uncomplicated childhood falciparum malaria","volume":"27","author":"Sirivichayakul","year":"2007","journal-title":"Ann. Trop. Paediatr."},{"key":"10.1016\/j.phymed.2022.154259_bib0155","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jphs.2022.01.007","article-title":"Artesunate induces ferroptosis via modulation of p38 and ERK signaling pathway in glioblastoma cells","volume":"148","author":"Song","year":"2022","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.phymed.2022.154259_bib0156","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S2213-2600(20)30222-8","article-title":"Pulmonary fibrosis secondary to COVID-19: a call to arms?","volume":"8","author":"Spagnolo","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.phymed.2022.154259_bib0157","article-title":"Anti-malarial drug artesunate inhibits primary human cultured airway smooth muscle cell proliferation","author":"Tan","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.phymed.2022.154259_bib0158","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4269\/ajtmh.2001.65.717","article-title":"Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria","volume":"65","author":"Teja-Isavadharm","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.phymed.2022.154259_bib0159","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1508606","article-title":"Four artemisinin-based treatments in African pregnant women with malaria","volume":"374","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2022.154259_bib0160","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00228-008-0506-6","article-title":"Absence of time-dependent artesunate pharmacokinetics in healthy subjects during 5-day oral administration","volume":"64","author":"Thuy","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0161","doi-asserted-by":"crossref","first-page":"31413","DOI":"10.18632\/oncotarget.8920","article-title":"Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt\/\u03b2-catenin signaling","volume":"7","author":"Tong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2022.154259_bib0162","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaci.2013.12.1035","article-title":"Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation","volume":"134","author":"Ullah","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.phymed.2022.154259_bib0163","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/jac\/dku154","article-title":"Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso","volume":"69","author":"Valea","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0164","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn1100","article-title":"Targeting programmed cell death in neurodegenerative diseases","volume":"4","author":"Vila","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phymed.2022.154259_bib0165","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2022.154259_bib0166","article-title":"Drug interactions between dolutegravir and artemether-lumefantrine or artesunate-amodiaquine","volume":"63","author":"Walimbwa","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2022.154259_bib0167","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3892\/mmr.2015.3500","article-title":"Anti-profibrotic effects of artesunate on bleomycin-induced pulmonary fibrosis in Sprague Dawley rats","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phymed.2022.154259_bib0170","article-title":"Artesunate modulates expression of matrix metalloproteinases and their inhibitors as well as collagen-IV to attenuate pulmonary fibrosis in rats","volume":"15","author":"Wang","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.phymed.2022.154259_bib0168","first-page":"2536","article-title":"Effect of artesunate on airway responsiveness and airway inflammation in asthmatic mice","volume":"32","author":"Wang","year":"2019","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.phymed.2022.154259_bib0169","first-page":"93","article-title":"Effects of artesunate on eosinophil apoptosis and expressions of Fas and Bcl-2 proteins in asthmatic mice","volume":"1","author":"Wang","year":"2020","journal-title":"J. South Med. Univ."},{"key":"10.1016\/j.phymed.2022.154259_bib0171","article-title":"Artesunate attenuates airway resistance in vivo and relaxes airway smooth muscle cells in vitro via bitter taste receptor-dependent calcium signalling","author":"Wang","year":"2018","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.phymed.2022.154259_bib0172","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003203","article-title":"Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: a pilot and a randomised volunteer infection study in Australia","volume":"17","author":"Watts","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.phymed.2022.154259_bib0173","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.rmed.2016.08.006","article-title":"Predictors of frequent exacerbations in (ex)smoking and never smoking adults with severe asthma","volume":"118","author":"Westerhof","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.phymed.2022.154259_bib0174","series-title":"WHO Coronavirus (COVID-19) Dashboard","year":"2021"},{"key":"10.1016\/j.phymed.2022.154259_bib0175","series-title":"The Top 10 Causes of Death","year":"2020"},{"key":"10.1016\/j.phymed.2022.154259_bib0176","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.3390\/ijms21155578","article-title":"The artemisinin-derived autofluorescent compound BG95 exerts strong Anticytomegaloviral activity based on a mitochondrial targeting mechanism","volume":"21","author":"Wild","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.phymed.2022.154259_bib0177","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.20112691","article-title":"Interleukin-1\u03b1 controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33","volume":"209","author":"Willart","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phymed.2022.154259_bib0178","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/thoraxjnl-2020-214764","article-title":"Induction of ferroptosis-like cell death of eosinophils exerts synergistic effects with glucocorticoids in allergic airway inflammation","volume":"75","author":"Wu","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.phymed.2022.154259_bib0179","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejmech.2015.11.003","article-title":"Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives","volume":"107","author":"Xu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phymed.2022.154259_bib0180","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/kem014","article-title":"Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase\/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes","volume":"46","author":"Xu","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.phymed.2022.154259_bib0181","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/kem014","article-title":"Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase\/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes","volume":"46","author":"Xu","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.phymed.2022.154259_bib0182","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2013.10.056","article-title":"Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells","volume":"133","author":"Xue","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.phymed.2022.154259_bib0183","doi-asserted-by":"crossref","first-page":"L615","DOI":"10.1152\/ajplung.00249.2012","article-title":"SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD","volume":"305","author":"Yao","year":"2013","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.phymed.2022.154259_bib0184","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107593","article-title":"Induction of programmed necrosis: a novel anti-cancer strategy for natural compounds","volume":"214","author":"Yu","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2022.154259_bib0185","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/his.14138","article-title":"Pulmonary pathology of early-phase COVID-19 pneumonia in a patient with a benign lung lesion","volume":"77","author":"Zeng","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.phymed.2022.154259_bib0186","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.7150\/jca.57054","article-title":"Artemisinin derivatives inhibit non-small cell lung cancer cells through induction of ROS-dependent Apoptosis\/Ferroptosis","volume":"12","author":"Zhang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.phymed.2022.154259_bib0187","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.7150\/jca.57054","article-title":"Artemisinin derivatives inhibit non-small cell lung cancer cells through induction of ROS-dependent Apoptosis\/Ferroptosis","volume":"12","author":"Zhang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.phymed.2022.154259_bib0188","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.0306-5251.2001.01461.x","article-title":"Multiple dose study of interactions between artesunate and artemisinin in healthy volunteers","volume":"52","author":"Zhang","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0189","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3736\/jcim20080206","article-title":"Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial","volume":"6","author":"Zhang","year":"2008","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"10.1016\/j.phymed.2022.154259_bib0190","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s10753-017-0524-6","article-title":"Artesunate protects LPS-induced acute lung injury by inhibiting TLR4 expression and inducing Nrf2 activation","volume":"40","author":"Zhao","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.phymed.2022.154259_bib0191","first-page":"186","article-title":"Distribution and excretion of artesunate in rats","volume":"4","author":"Zhao","year":"1989","journal-title":"Proc. Chin. Acad. Med. Sci. Peking Union Med. Coll."},{"key":"10.1016\/j.phymed.2022.154259_bib0192","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.intimp.2011.08.017","article-title":"Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2\/M phase","volume":"11","author":"Zhao","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2022.154259_bib0193","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1002\/jcp.24086","article-title":"Artesunate induces apoptosis via a Bak-mediated caspase-independent intrinsic pathway in human lung adenocarcinoma cells","volume":"227","author":"Zhou","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.phymed.2022.154259_bib0194","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/CAD.0b013e328364a109","article-title":"Artesunate inhibits the growth of gastric cancer cells through the mechanism of promoting oncosis both in vitro and in vivo","volume":"24","author":"Zhou","year":"2013","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.phymed.2022.154259_bib0195","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-021244","article-title":"Trends in asthma hospital admissions and mortality in Kuwait, 2000-2014: a national retrospective observational study","volume":"8","author":"Ziyab","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.phymed.2022.154259_fur1","first-page":"567","article-title":"Effects of artesunate on the invasion of lung adenocarcinoma A549 cells and expression of ICAM-1 and MMP-9","volume":"16","author":"Chen","year":"2013","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"10.1016\/j.phymed.2022.154259_fur2","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-13-281","article-title":"Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study","volume":"13","author":"Li","year":"2014","journal-title":"Malar. J."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711322003385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711322003385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:00:06Z","timestamp":1789768806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711322003385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":195,"alternative-id":["S0944711322003385"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2022.154259","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artesunate: A review of its therapeutic insights in respiratory diseases","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2022.154259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154259"}}